MCRC
Clinical trials for MCRC explained in plain language.
Never miss a new study
Get alerted when new MCRC trials appear
Sign up with your email to follow new studies for MCRC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New biosimilar takes on standard therapy in advanced colon cancer trial
Disease control Not yet recruitingThis early-stage trial tests whether a new drug called HLX05-N works as well as the approved drug ERBITUX in people with metastatic colorectal cancer that has certain genetic features. About 387 adults will receive either the new drug or ERBITUX, plus chemotherapy. The study meas…
Matched conditions: MCRC
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
New hope for advanced colon cancer: drug duo targets tumors
Disease control Not yet recruitingThis study tests a new drug combination (SHR-1811 plus bevacizumab) as a second-line treatment for people with metastatic colorectal cancer that has worsened after initial therapy. About 80 adults aged 18-75 will participate to see if the combo shrinks tumors and delays cancer gr…
Matched conditions: MCRC
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for advanced colon cancer: drug cocktail plus radiation tested
Disease control Not yet recruitingThis study is for people with metastatic colorectal cancer that has spread to a few spots (like the liver or lungs) and hasn't responded to at least two prior treatments. It tests whether adding two immunotherapy drugs (iparomlimab and tuvonralimab) plus targeted radiation to the…
Matched conditions: MCRC
Phase: PHASE2 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 18, 2026 11:59 UTC